Holley (HLLY) Q1 2026 earnings review

Margin Discipline Masks a Revenue Reversal

Holley's growth streak snapped in Q1 as revenue fell 3.7% to $147.3M, reversing the momentum built in late 2025. The contraction was driven by severe winter weather and bloated distributor inventories. However, the bottom line tells a different story. Relentless cost controls, proactive tariff mitigation, and a $6.5M reduction in expenses drove a massive 158% surge in Net Income. Management is now pivoting toward "addition by subtraction"—cutting $15M in full-year revenue guidance to shed 11,000 unprofitable SKUs, a move expected to generate $15M in cash while leaving EBITDA targets intact.

🐂 Bull Case

Profitability Over Volume

Despite a top-line miss, gross profit metrics and net income improved dramatically. Cost control initiatives yielded $6.5M in savings, expanding Adjusted EBITDA margins by 71 bps YoY to 18.5%.

Shedding Dead Weight

The Portfolio Optimization initiative will eliminate 11,000 low-to-no-profit SKUs. While it trims $15M from the top-line guidance, it will generate >$15M in incremental cash and reduce operating complexity.

🐻 Bear Case

Growth Engine Stalls

After strong 10.9% growth in 25Q4, Q1 sales contracted 3.7%. Weather and channel inventories were blamed, but the sudden reversal raises questions about underlying consumer demand.

Cash Burn Lingers

Free Cash Flow remained negative at $(6.3)M. While this is an improvement from $(10.8)M a year ago, the company must execute its SKU rationalization perfectly to generate meaningful cash in a tough macro environment.

⚖️ Verdict: ⚪

Neutral. Management is executing brilliantly on the cost side, completely neutralizing a top-line decline to deliver earnings growth. However, sacrificing revenue to protect margins is a strategy with a natural ceiling. We need to see volume recovery in Q2.

Key Themes

DRIVERNEW🟢

Addition by Subtraction: Portfolio Optimization

Holley is aggressively pruning its product catalog. The company announced a Portfolio Optimization initiative that will cut more than 11,000 underperforming SKUs. Management explicitly reduced FY26 revenue guidance by $15M to account for this, but expects the net impact on Adjusted EBITDA to be slightly positive. Crucially, liquidating this working capital is expected to generate over $15M in incremental cash.

DRIVER🟢

Relentless Cost Controls Protect Margins

Management delivered $6.5M in Q1 cost savings stemming from purchasing, operations, and proactive tariff management. This discipline allowed the company to expand Adjusted EBITDA margins to 18.5% (up 71 bps YoY) despite a 3.7% drop in net sales, proving that their structural profitability improvements from 2025 are sticking.

CONCERNNEW🔴

Weather and Channel Inventories Snap Growth

Revenue growth reversed sharply. Management cited elevated distributor inventory levels entering the quarter and severe winter weather in late January and early February as primary culprits. While order activity reportedly improved from "week eight onward," the sudden return to negative growth highlights the fragility of the aftermarket auto consumer in a high-rate macro environment.

DRIVERNEW🟢

M&A Re-engagement via HRX

Holley acquired HRX, a targeted bolt-on deal expanding its racewear capabilities and deepening its European motorsports presence. This signals a return to M&A for the first time since their major deleveraging phase began in late 2023, indicating management believes the balance sheet is now strong enough to support inorganic growth.

CONCERN🔴

Working Capital Efficiency Needs Improvement

Despite ongoing focus, inventory actually crept up to $210.5M from $205.6M at year-end 2025. This buildup contributed to negative Free Cash Flow of $(6.3)M in the quarter. The success of the newly announced 11,000 SKU rationalization will be vital to reversing this trend and preventing cash lockup.

Other KPIs

Bank-adjusted EBITDA Leverage Ratio (TTM)3.84x

Stable. Up slightly from 3.75x at the end of FY25, but well below the 4.17x seen at the end of FY24. The company maintains comfortable headroom under its credit agreement, allowing them to shift focus back toward targeted M&A like the HRX acquisition.

Gross Profit$60.7 million

Decelerating. Dropped 5.2% YoY from $64.1M in 25Q1. Cost of goods sold did not fall as fast as revenue (-2.7% vs -3.7%), resulting in minor gross margin compression before operating expenses were factored in.

Interest Expense, Net$9.9 million

Accelerating improvement. Interest expense dropped nearly 37% YoY from $15.7M in 25Q1, a direct result of Holley's aggressive $100M debt paydown throughout 2024 and 2025. This massive saving below the operating line was the primary driver of the 158% surge in Net Income.

Guidance

FY26 Net Sales$610 - $640 million

Reversing. Downward revision from prior guidance of $625 - $655 million. The entire $15M reduction is attributed to the planned exit of non-core, low-to-no-profit businesses. The midpoint of $625M implies an acceleration to roughly 1.9% YoY growth against FY25's $613.5M base, requiring a material pickup in the remaining three quarters.

FY26 Adjusted EBITDA$127 - $137 million

Stable. Guidance remains completely unchanged despite the $15M cut to the top line. This implies that the revenue being shed generated zero or negative EBITDA, and underscores management's confidence in their $6.5M Q1 cost savings extending throughout the year. The $132M midpoint implies 6.5% YoY growth.

FY26 Capital Expenditures$15 - $20 million

Stable. Maintained at prior levels. This elevated rate relative to historical norms supports ongoing facility consolidations and the early stages of a new ERP/WMS implementation aimed for 2027.

Key Questions

SKU Rationalization Nuance

You are shedding 11,000 SKUs to generate $15M in cash. What is the timeline for this liquidation, and will it require heavy discounting that could temporarily pressure gross margins in Q2 or Q3?

HRX Acquisition Impact

Can you provide color on the financial profile of the HRX acquisition? How much revenue and EBITDA does this add to the FY26 run-rate, and are these figures embedded in the current unchanged EBITDA guidance?

Distributor Inventory Health

You noted elevated distributor inventory entering Q1 that disrupted purchasing patterns. Did the improved sell-through post-week 8 fully normalize these channels, or should we expect cautious ordering to persist into the summer months?